|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.244
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.234
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.202
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.191
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.180
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.165
|
|
|
cation transport
|
GO:0006812 |
399 |
0.152
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.150
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.135
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.132
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.124
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.124
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.113
|
|
|
anion transport
|
GO:0006820 |
177 |
0.110
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.094
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.093
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.092
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.091
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.086
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.082
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.075
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.072
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.067
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.067
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.065
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.064
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.063
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.063
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.063
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.062
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.061
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.058
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.058
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.055
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.054
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.054
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.053
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.053
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.053
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.053
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.052
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.052
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.051
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.050
|
|
|
protein processing
|
GO:0016485 |
163 |
0.050
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.050
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.050
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.050
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.049
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.049
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.048
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.047
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.047
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.047
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.047
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.047
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.046
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.046
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.046
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.045
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.045
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.045
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.045
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.044
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.043
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.043
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.043
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.043
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.042
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.042
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.041
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.041
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.040
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.040
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.039
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.039
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.039
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.038
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.038
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.038
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.037
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.037
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.037
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.037
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.036
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.036
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.036
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.036
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.036
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.036
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.035
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.035
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.034
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.034
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.034
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.033
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.033
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.033
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.033
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.033
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.032
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.032
|
|
|
negative regulation of dna binding
|
GO:0043392 |
20 |
0.032
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.031
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.031
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.031
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.031
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.031
|
|
|
kidney development
|
GO:0001822 |
213 |
0.030
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.030
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.030
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.030
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.029
|
|
|
neuron death
|
GO:0070997 |
154 |
0.029
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.029
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.029
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.028
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.028
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.028
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.028
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.027
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.027
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.027
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.027
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.026
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.026
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.026
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.025
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.025
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
renal system development
|
GO:0072001 |
225 |
0.025
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.025
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.025
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.025
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.025
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.024
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.024
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.024
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.024
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.024
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.024
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.024
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.024
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.024
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.024
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.023
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.023
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.023
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.023
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.023
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.023
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.023
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.023
|
|
|
trabecular meshwork development
|
GO:0002930 |
2 |
0.022
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.022
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.022
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.022
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.022
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.022
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.022
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.022
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.022
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.022
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.021
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.021
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.021
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.021
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.021
|
|
|
defecation
|
GO:0030421 |
1 |
0.021
|
|
|
cognition
|
GO:0050890 |
149 |
0.021
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.021
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.021
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.021
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.021
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.021
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.020
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.020
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.020
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.020
|
|
|
pallium development
|
GO:0021543 |
120 |
0.020
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.020
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.020
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.020
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.020
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.020
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.019
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.019
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.019
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.019
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.019
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.019
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.019
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.019
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.019
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.019
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.019
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.019
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.019
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.019
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.019
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.019
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.019
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.019
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.018
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.018
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.018
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.018
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.018
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
methylation
|
GO:0032259 |
134 |
0.018
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.018
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.018
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.018
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.018
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.018
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.018
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.017
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.017
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.017
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.017
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.017
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.017
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.017
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.017
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.017
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.017
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.017
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.017
|
|
|
insulin secretion involved in cellular response to glucose stimulus
|
GO:0035773 |
36 |
0.017
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.017
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.016
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.016
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.016
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.016
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.016
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.016
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.016
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.016
|
|
|
cell cell signaling involved in metanephros development
|
GO:0072204 |
2 |
0.016
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.016
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.016
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.016
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.016
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
regulation of transcription regulatory region dna binding
|
GO:2000677 |
9 |
0.016
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.016
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.016
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.016
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.016
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.015
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.015
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
regulation of transcription by glucose
|
GO:0046015 |
3 |
0.015
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.015
|
|
|
histone modification
|
GO:0016570 |
159 |
0.015
|
|
|
rna processing
|
GO:0006396 |
105 |
0.015
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.015
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.015
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.015
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.015
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.015
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.015
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.015
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.015
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.015
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.015
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.015
|
|
|
dna repair
|
GO:0006281 |
107 |
0.015
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.015
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.015
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.015
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.015
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.014
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.014
|
|
|
metanephric capsule morphogenesis
|
GO:0072265 |
1 |
0.014
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.014
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.014
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.014
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.014
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.014
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.014
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.014
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.014
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.014
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.014
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
neural fold elevation formation
|
GO:0021502 |
1 |
0.014
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.014
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.014
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.014
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.014
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.014
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.014
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.014
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.014
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.014
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.014
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.014
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.014
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.013
|
|
|
response to drug
|
GO:0042493 |
75 |
0.013
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.013
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.013
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.013
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.013
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.013
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.013
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.013
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.013
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.013
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.013
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.013
|
|
|
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000702 |
1 |
0.013
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.013
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.013
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.013
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.013
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.013
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.013
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.013
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.013
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.013
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.013
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.013
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
7 |
0.013
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.013
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.013
|
|
|
cervix development
|
GO:0060067 |
2 |
0.013
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.013
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.013
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.013
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.013
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.013
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.013
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.013
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.013
|
|
|
cell cell signaling involved in kidney development
|
GO:0060995 |
2 |
0.013
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.013
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.013
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.013
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.013
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.013
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.013
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.013
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.013
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.013
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.013
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.012
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.012
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.012
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.012
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
renal capsule morphogenesis
|
GO:0072128 |
1 |
0.012
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.012
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.012
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.012
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.012
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.012
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.012
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.012
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.012
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.012
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.012
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.012
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.012
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.012
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.012
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.012
|
|
|
columnar cuboidal epithelial cell maturation
|
GO:0002069 |
4 |
0.012
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.012
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.012
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.012
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.012
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.012
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.012
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.012
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.012
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.012
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.012
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.012
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.012
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.012
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.012
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.012
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.012
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.012
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.012
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.012
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.012
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.012
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.012
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.012
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.011
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.011
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.011
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.011
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.011
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.011
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.011
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.011
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.011
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.011
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.011
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.011
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.011
|
|